Oxaliplatin Export Market Intelligence: India's 249 Suppliers Shipping to 123 Countries — TransData Nexus 2026

Q: Who are the top oxaliplatin exporters from India?

The top oxaliplatin exporters from India are: 1. FRESENIUS KABI ONCOLOGY LIMITED — $16.6M (35.7% market share); 2. JODAS EXPOIM PRIVATE LIMITED — $5.8M (12.5% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $3.6M (7.7% market share); 4. ACCURE LABS PRIVATE LIMITED — $2.6M (5.5% market share); 5. GLAND PHARMA LIMITED — $2.2M (4.7% market share). Together they account for 66.1% of India's total oxaliplatin export value.

Q: What is the total export value of oxaliplatin from India?

The total export value of oxaliplatin from India is $46.6M USD, recorded across 3,081 shipment transactions from 249 active exporters to 123 destination countries. The average shipment value is $15.1K.

Q: Which countries import oxaliplatin from India?

India exports oxaliplatin to 123 countries worldwide. The top importing countries are: GERMANY (21.5% share, $10.0M), RUSSIA (13.9% share, $6.5M), UNITED STATES (9.4% share, $4.4M), THAILAND (7.4% share, $3.4M), ALGERIA (6.3% share, $2.9M). These five markets account for 58.5% of total export value.

Q: What is the HS code for oxaliplatin exports from India?

The primary HS code for oxaliplatin exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of oxaliplatin exports from India?

The average unit price for oxaliplatin exports from India is $11.37 USD per unit, with prices ranging from $0.01 to $1089.32 depending on formulation, packaging, and order volume. The total market is valued at $46.6M across 3,081 shipments.

Q: Which ports handle oxaliplatin exports from India?

The primary ports for oxaliplatin exports from India are DELHI AIR CARGO ACC (INDEL4) (17.4% of shipments), SAHAR AIR CARGO ACC (INBOM4) (14.7% of shipments), DELHI AIR (14.2% of shipments), SAHAR AIR (13.3% of shipments), CHAWAPAYAL ICD (INCPR6) (3.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of oxaliplatin?

India is one of the world's leading exporters of oxaliplatin due to its large base of 249 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports oxaliplatin to 123 countries, demonstrating 63% global market coverage.

Q: What certifications do Indian oxaliplatin exporters need?

Indian oxaliplatin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import oxaliplatin from India?

There are 693 registered buyers importing oxaliplatin from India, spread across 123 countries. The repeat buyer rate is 62.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top oxaliplatin supplier from India?

FRESENIUS KABI ONCOLOGY LIMITED is the leading oxaliplatin exporter from India with a market share of 35.7% and total export value of $16.6M across 602 shipments. The top 5 suppliers together control 66.1% of total export value.

Suresh Sormare

Oxaliplatin

India Pharmaceutical Trade Intelligence

$46.6M249 Suppliers123 CountriesHS 30049049

ExportsIndia → GERMANY21.5%India → RUSSIA13.9%

ImportsARGENTINA → India$44.5K ITALY → India$20.0K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Oxaliplatin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Oxaliplatin to the World

Between 2022 and 2026, India exported $46.6M worth of oxaliplatin across 3,081 verified shipments to 123 countries — covering 63% of world markets in the Advanced Oncology segment. The largest destination is GERMANY (21.5%). FRESENIUS KABI ONCOLOGY LIMITED leads with a 35.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Oxaliplatin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Oxaliplatin export data snapshot — $46.6M · 249 exporters · 123 countriesTransData Nexus · Indian Customs Data

Top Oxaliplatin Exporters from India

249 active exporters · Ranked by export value

View all 249 →

Top Oxaliplatin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	FRESENIUS KABI ONCOLOGY LIMITED	$16.6M	602	24	35.7%
2	JODAS EXPOIM PRIVATE LIMITED

Top Countries Importing Oxaliplatin from India

123 destination markets · Ranked by import value

All 123 countries →

Top Countries Importing Oxaliplatin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GERMANY	$10.0M	21.5%
2	RUSSIA	$6.5M	13.9%
3	UNITED STATES	$4.4M	9.4%
4	THAILAND	$3.4M	7.4%
5	ALGERIA	$2.9M	6.3%
6	BELGIUM	$2.6M	5.6%
7	COLOMBIA	$1.6M	3.4%
8	PHILIPPINES	$1.2M	2.6%
9	MOROCCO	$1.1M	2.4%
10	MALAYSIA	$869.7K	1.9%

GERMANY is India's largest oxaliplatin export destination, absorbing 21.5% of total exports worth $10.0M. The top 5 importing countries — GERMANY, RUSSIA, UNITED STATES, THAILAND, ALGERIA — together account for 58.5% of India's total oxaliplatin export value. The remaining 118 destination countries collectively receive the other 41.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Oxaliplatin to India?

7 origin countries · Total import value: $77.5K

India imports oxaliplatin from 7 countries with a combined import value of $77.5K. The largest supplier is ARGENTINA ($44.5K, 1 shipments), followed by ITALY and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Oxaliplatin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ARGENTINA	$44.5K	1	57.4%
2	ITALY	$20.0K	2	25.8%
3	CHINA	$7.1K	1	9.2%
4	SWITZERLAND	$4.3K	4	5.6%
5	UNITED STATES	$1.1K	4	1.5%
6	GERMANY	$217	2	0.3%
7	THAILAND	$165	10	0.2%

ARGENTINA is the largest supplier of oxaliplatin to India, accounting for 57.4% of total import value. The top 5 origin countries — ARGENTINA, ITALY, CHINA, SWITZERLAND, UNITED STATES — together supply 99.5% of India's oxaliplatin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Oxaliplatin — Export Intelligence Video

Visual overview of India's oxaliplatin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's oxaliplatin pharmaceutical import and export market — $46.6M in total trade, 249 verified manufacturers, and 123 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Oxaliplatin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, oxaliplatin was initially approved by the FDA in August 2002 under the brand name Eloxatin. Generic versions received approval starting in August 2009. However, patent disputes led to a temporary halt in generic production in 2010, which resumed in 2012. As of February 2026, all original Eloxatin formulations have been discontinued. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for oxaliplatin, indicating a competitive generic market. Notably, the United States accounted for 9.4% of India's oxaliplatin exports between 2022 and 2026, underscoring the significance of the U.S. market for Indian exporters.

2EU & UK Regulatory Framework

Oxaliplatin received European approval in 1996. The European Medicines Agency (EMA) continues to monitor its safety and efficacy. For instance, in February 2025, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorization for Columvi, a medicinal product that includes oxaliplatin in combination with gemcitabine for treating certain types of lymphoma. This reflects ongoing regulatory oversight and adaptation to emerging clinical data. Compliance with EU Good Manufacturing Practice (GMP) standards is mandatory for manufacturers exporting to the EU and UK, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Oxaliplatin is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its importance in cancer treatment. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality parameters across different regions.

4India Regulatory Classification

In India, oxaliplatin is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for exporting pharmaceuticals, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for oxaliplatin have expired, with the last significant patent (US Patent No. 5,420,319) expiring on August 8, 2016. This has led to increased generic competition globally, including from Indian manufacturers.

6Recent Industry Developments

In February 2025, the EMA's CHMP adopted a positive opinion recommending a change to the marketing authorization for Columvi, a medicinal product that includes oxaliplatin in combination with gemcitabine for treating certain types of lymphoma. This reflects ongoing regulatory oversight and adaptation to emerging clinical data.

In September 2022, a patent (CN111205332A) was filed describing the development of oxaliplatin co-crystals using flavonoids to improve solubility and stability in the gastrointestinal tract, potentially reducing side effects. This innovation could influence future formulations and therapeutic applications.

These developments underscore the dynamic nature of the regulatory and industrial landscape surrounding oxaliplatin, with implications for manufacturers, exporters, and healthcare providers.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Oxaliplatin

Retail & reference prices across 9 markets vs. India FOB export price of $11.37/unit

Global Price Benchmark for Oxaliplatin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1,200	USD	According to the FDA's Orange Book, Oxaliplatin is approved for use in the United States.
United Kingdom	$780	GBP	The UK's National Health Service (NHS) includes Oxaliplatin in its Drug Tariff, indicating its availability and regulated pricing within the public healthcare system.
Germany	$770	EUR	The European Medicines Agency (EMA) has authorized the use of Oxaliplatin across member states, including Germany.
Australia	$700

Supply Chain Risk Assessment — Oxaliplatin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Oxaliplatin, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. This dependency exposes the supply chain to vulnerabilities stemming from geopolitical tensions and regulatory changes. For instance, in June 2025, environmental regulations in China led to the shutdown of several chemical manufacturing plants, causing significant disruptions in the supply of KSMs to Indian API manufacturers. Such events underscore the fragility of the supply chain due to over-reliance on a single source for critical raw materials.

The COVID-19 pandemic further highlighted these vulnerabilities. During the early months of 2020, lockdowns and transportation restrictions in China resulted in delays and shortages of essential KSMs, impacting the production timelines of Indian pharmaceutical companies. These incidents emphasize the need for diversification in sourcing strategies to mitigate risks associated with supply chain disruptions.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Oxaliplatin from India account for 66.1% of the total export value, with FRESENIUS KABI ONCOLOGY LIMITED alone contributing 35.7%. This high level of supplier concentration poses a significant risk, as any operational or financial issues within these key companies could disrupt the entire supply chain.

Access Complete Oxaliplatin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,081 transactions across 123 markets.

Request Demo View Pricing

Frequently Asked Questions — Oxaliplatin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top oxaliplatin exporters from India?

The leading oxaliplatin exporters from India are FRESENIUS KABI ONCOLOGY LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 12 others. FRESENIUS KABI ONCOLOGY LIMITED leads with 35.7% market share ($16.6M). The top 5 suppliers together control 66.1% of total export value.

What is the total export value of oxaliplatin from India?

The total export value of oxaliplatin from India is $46.6M, recorded across 3,081 shipments from 249 active exporters to 123 countries. The average shipment value is $15.1K.

Which countries import oxaliplatin from India?

India exports oxaliplatin to 123 countries. The top importing countries are GERMANY (21.5%), RUSSIA (13.9%), UNITED STATES (9.4%), THAILAND (7.4%), ALGERIA (6.3%), which together account for 58.5% of total export value.

What is the HS code for oxaliplatin exports from India?

The primary HS code for oxaliplatin exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Oxaliplatin

Oxaliplatin

Top Oxaliplatin Exporters from India

Top Countries Importing Oxaliplatin from India

Who Supplies Oxaliplatin to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Oxaliplatin — Export Intelligence Video

Regulatory Landscape — Oxaliplatin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Oxaliplatin

Supply Chain Risk Assessment — Oxaliplatin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Oxaliplatin Trade Intelligence

Frequently Asked Questions — Oxaliplatin Exports from India

Who are the top oxaliplatin exporters from India?

What is the total export value of oxaliplatin from India?

Which countries import oxaliplatin from India?

What is the HS code for oxaliplatin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of oxaliplatin exports from India?

Which ports handle oxaliplatin exports from India?

Why is India a leading exporter of oxaliplatin?

What certifications do Indian oxaliplatin exporters need?

How many buyers import oxaliplatin from India?

What is the market share of the top oxaliplatin exporter from India?

Analysis Methodology